Are electronic signatures legally valid?

Yes. Electronic signatures are legally enforceable in interstate commerce under the ESIGN Act (15 U.S.C. §7001) and in most states under UETA; ensure intent, consent, attribution, and retention are met.

Do I need Part 11 controls for FDA submissions?

If electronic records or signatures are used to meet FDA requirements, implement 21 CFR Part 11 controls for audit trails, access controls, and signature linking to maintain compliance.

How should PHI be handled in submissions?

Limit PHI to the minimum necessary, secure transmission and storage with encryption, and ensure a Business Associate Agreement (BAA) with vendors where HIPAA applies (45 CFR §164.502).

What if a signer makes an error?

Avoid altering signed originals; execute an amendment or correction document with appropriate signatures and an audit record that explains the change and who authorized it.

Is notarization required for FDA documents?

Not typically required for FDA submissions themselves, but certain legal attestations or state-governed instruments may require notarization or witnesses; verify per-document and per-state.

How strong must signer authentication be?

Authentication should match the risk profile: simple email for low-risk attestations, stronger methods (SMS OTP, knowledge-based, or multi-factor) where legal or institutional policies require higher assurance.

Electronic Signature
Templates
Healthcare
Healthcare FDA Document

Healthcare FDA Document

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Authorization to Disclose Health Information to the FDA for Medical Product Review

Patient Information

Patient Name:

Date of Birth: Gender:

Address Phone Emergency Contact

Insurance & Coverage

Insurance Provider Policy / Group Number Subscriber Name (if different)

Medical History & Product Information

Current Medications Known Allergies Prior Surgeries / Procedures Chronic Conditions (select all that apply)

Diabetes
Cardiac disease
Respiratory disease
Renal disease
Other (specify below)

If Other, specify Medical Product / Device Information

Product/Device Name:

Model / Lot / Serial #:

Date of Implant / Use:

Device implanted or permanently affixed
Temporary device or short-term use
Enrolled in clinical investigation relating to this product

Authorization to Disclose

I hereby authorize my health care providers, health plans, medical facilities, and their agents to disclose my protected health information to the United States Food and Drug Administration (FDA), its authorized representatives, and to manufacturer(s) or distributors of the medical product(s) named above. This authorization applies to medical and billing records, operative and procedure reports, imaging, device identifiers (including lot and serial numbers), laboratory results, pharmacy and prescription records, adverse event reports, claims information, and other records reasonably related to evaluation of the safety or effectiveness of the product.

Purpose: The purpose of this disclosure is post-market surveillance, safety monitoring, adverse event investigation, regulatory compliance, and related public health activities. Information disclosed under this authorization may be used by recipients for these purposes.

Rights, Limitations, and Acknowledgements

Revocation: I understand that I may revoke this authorization at any time by providing a written notice to the health care provider or facility listed below. Revocation will not affect disclosures already made in reliance on this authorization prior to receipt of the revocation.

Redisclosure: I understand that information disclosed pursuant to this authorization may be subject to federal laws and regulations and may be further disclosed by the FDA or manufacturer in compliance with law. Such redisclosure may not be protected by state privacy rules.

Right to Inspect and Copy: I understand that I have the right to inspect and obtain a copy of the health information disclosed pursuant to this authorization in accordance with applicable law, except where prohibited.

Voluntariness and Effect of Refusal: I understand that signing this authorization is voluntary. My refusal to sign will not affect my right to obtain treatment, payment, enrollment, or eligibility for benefits, except where the provision of the information is required for the health care provider to obtain payment or for the FDA to carry out required regulatory functions.

Acknowledgments (check to confirm)

I understand the purpose of this authorization and the intended recipients of my information.
I have been offered a copy of this signed authorization.
I acknowledge receipt of the facility's privacy practices and notice of patient rights.

Expiration of Authorization

If no date is provided above, this authorization will expire one year from the date signed below or sooner if required by state law.

Facility / Provider to Release Information

Name of Organization Releasing Records Contact / Records Office

Certification & Signature

By signing below I certify that I am the patient or authorized representative with legal authority to sign on the patient's behalf. I certify that the information I have provided on this form is true and correct to the best of my knowledge and that I authorize the disclosures described above.

Printed Name:

Signature:

Date:

If signed by authorized representative, print name:

Relationship to patient:

What the Healthcare FDA Document Is and when it applies

A Healthcare FDA Document is any clinical, regulatory, or administrative record prepared for submission to the U.S. Food and Drug Administration or used to support FDA-regulated activities in healthcare. Examples include study submissions, adverse event reports, device or drug application attachments, and protocol amendments. These documents must meet both FDA-specific requirements (including 21 CFR Part 11 where electronic records/signatures are used) and broader U.S. e-signature laws (ESIGN and state UETA statutes). They also frequently intersect with HIPAA when protected health information is included.

Why accurate Healthcare FDA Documents matter

Accurate, compliant documents reduce regulatory risk, speed review, and preserve legal validity for clinical and commercial activities. Precise metadata, signatures, and retention practices help defend submissions in audits and inspections while protecting patient privacy under HIPAA.

Who prepares and signs Healthcare FDA Documents

Multiple stakeholders create, review, and sign these documents; responsibilities depend on the document type and organizational role.

Clinical sponsors and regulatory affairs teams who compile submission packages and maintain study records.
Principal investigators and site staff who collect and attest to clinical data and informed consent.
Legal, quality assurance, and privacy officers who review for compliance with FDA, HIPAA, and institutional policies.

Clear role assignment and documented authority reduce delays during review and prevent rejections for missing or invalid signatures.

Typical signatories and their responsibilities

Sponsor Representative

A corporate officer or designated regulatory affairs delegate who certifies submission accuracy, ensures required attachments are included, and confirms consent to electronic delivery and record retention for the organization.

Principal Investigator

An authorized clinician who verifies clinical data integrity, signs attestations or protocol confirmations, and accepts responsibility for site-level recordkeeping and timely adverse event notifications.

Security and compliance controls to include

In-transit encryption: TLS 1.2/1.3

At-rest encryption: AES-256

Audit trail: Timestamped activity logs

HIPAA support: BAA available

21 CFR Part 11: Controls for electronic records

Third-party audits: SOC 2 Type II

Primary risks if the document is incorrect or incomplete

HIPAA violation: Civil penalties possible

FDA rejection: Submission deemed noncompliant

Invalid signature: Legal challenges to validity

Data breach: Notification obligations triggered

Late reporting: Compliance sanctions risk

Audit findings: Corrective action plans required

Step-by-step: preparing a Healthcare FDA Document

Follow a clear sequence to prepare, validate, and submit documents to reduce review cycles and maintain compliance.

01

Assemble records: Collect all required attachments and source documents before drafting.
02

Verify identities: Confirm signer authority and acceptable ID methods for e-signature.
03

Complete fields: Fill required fields, use MM/DD/YYYY for dates, and avoid ambiguous terms.
04

Sign and submit: Capture signatures with an audit trail and deliver to the FDA or filing recipient.

Typical online workflow configuration for e-submission

Configure a secure signing workflow that preserves attribution, supports required authentication, and records a complete audit trail.

Field	Configuration
Signer Authentication	Email link or SMS OTP; use stronger methods if required
Conditional Fields	Show or hide sections based on prior answers
Audit Retention	Retain logs and timestamps for regulatory review
Attachments Allowed	Permit PDF/CSV/Word; validate file sizes and formats

Typical eSubmission flow for a Healthcare FDA Document

An efficient digital process reduces manual steps and ensures required metadata and signatures are captured in order.

Upload document: Sender uploads final PDF or DOCX to the platform.
Place fields: Designate signature, date, and data fields on the file.
Authenticate signer: Choose email, SMS, or stronger verification methods.
Submit and archive: Send to recipient and preserve signed copy with audit trail.

Key components of a professional Healthcare FDA Document

A complete document combines clear identification, required regulatory content, compliance attestations, and durable signature evidence to support FDA review and internal governance.

Cover Letter

Concise submission summary stating purpose, included attachments, and contact information for the responsible regulatory contact; helps reviewers locate key items quickly.

Identification

Clear product, protocol, IND/IDE, or device identifiers plus sponsor and site details so the submission is accurately assigned within FDA systems and sponsor files.

Clinical Data

Well-organized tables and narratives that summarize study results, safety information, and statistical analysis plans with clear links to source documents.

Regulatory Statements

Declarations that attest to accuracy, compliance with applicable regulations, and any required certifications or attestations by authorized signers.

Signatures

Legible signature blocks with printed names, titles, dates and an audit trail that records signer identity, IP, and timestamp per 21 CFR Part 11 requirements.

Appendices

Supporting materials such as consent forms, case report forms, and device specifications attached in a standardized, searchable order for inspection readiness.

Practical tips for accurate and efficient completion

Follow these best practices to reduce review cycles and maintain compliance when preparing Healthcare FDA Documents.

Confirm signer authority

Document that each signer has delegated authority; attach power of attorney or role designation when signatory authority is not obvious from title alone.

Preserve the audit trail

Retain timestamped logs, IP addresses, and authentication evidence to meet 21 CFR Part 11 and ESIGN record reproduction requirements during audits.

Use HIPAA safeguards

When PHI is present, ensure a BAA is in place and apply least-privilege access controls plus encryption in transit and at rest.

Validate dates and identifiers

Check MM/DD/YYYY formatting, protocol numbers, and device IDs carefully; inconsistent identifiers are a common cause of processing delays.

eSignature vendor comparison for Healthcare FDA Documents

Compare core pricing and key compliance features. signNow is shown first per table convention. Do not rely on this table for procurement decisions without vendor verification.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial, no card	Varies	Varies	Varies	Varies
Bulk Send	Yes	Yes	Yes	Yes	Varies
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies	Varies	Varies

Frequently asked questions about Healthcare FDA Documents and e-signatures

Answers to common questions about legal validity, HIPAA handling, signature corrections, and authentication methods for FDA-related healthcare paperwork.

Need help? Contact support

Are electronic signatures legally valid?
Yes. Electronic signatures are legally enforceable in interstate commerce under the ESIGN Act (15 U.S.C. §7001) and in most states under UETA; ensure intent, consent, attribution, and retention are met.
Do I need Part 11 controls for FDA submissions?
If electronic records or signatures are used to meet FDA requirements, implement 21 CFR Part 11 controls for audit trails, access controls, and signature linking to maintain compliance.
How should PHI be handled in submissions?
Limit PHI to the minimum necessary, secure transmission and storage with encryption, and ensure a Business Associate Agreement (BAA) with vendors where HIPAA applies (45 CFR §164.502).
What if a signer makes an error?
Avoid altering signed originals; execute an amendment or correction document with appropriate signatures and an audit record that explains the change and who authorized it.
Is notarization required for FDA documents?
Not typically required for FDA submissions themselves, but certain legal attestations or state-governed instruments may require notarization or witnesses; verify per-document and per-state.
How strong must signer authentication be?
Authentication should match the risk profile: simple email for low-risk attestations, stronger methods (SMS OTP, knowledge-based, or multi-factor) where legal or institutional policies require higher assurance.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now